Work

18F-FDG-PET/CT imaging to assess response to treatment with cabozantinib at 4 weeks versus 8 weeks of therapy in patients (pts) with metastatic urothelial carcinoma (mUC).

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.6_suppl.317

Authors: Nicole N. Davarpanah, Liza Lindenberg, Dereck W Paul, Seth M. Steinberg, Deneise C Francis, Marilise Anne Berniger, Juanita Weaver, Yolanda McKinney, Howard L. Parnes, Peter L. Choyke, Andrea B. Apolo

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research

Language: English

Topic: Medical Imaging Techniques and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2602030185

Cites:

Cited by:

Related to: 10